Aio-studien-ggmbh
Clinical trials sponsored by Aio-studien-ggmbh, explained in plain language.
-
Can lung cancer patients skip a drug break for radiation?
Disease control OngoingThis study aims to find out if it's safe and effective for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) to continue taking their daily oral medication, osimertinib, while also receiving radiation therapy. It involves 42 participants who need radiation…
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Common pain drug tested as secret weapon against tough colon cancer
Disease control OngoingThis early-stage trial is testing whether adding the pain medication methadone to a standard chemotherapy regimen (mFOLFOX6) can help control advanced colorectal cancer that has stopped responding to other treatments. The study first aims to find a safe dose of the combination, t…
Phase: PHASE1, PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC